Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2007 1
2008 1
2009 1
2011 1
2012 1
2013 2
2014 5
2015 6
2016 14
2017 16
2018 16
2019 17
2020 17
2021 34
2022 45
2023 40
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jingwu wang (24 results)?
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial.
Zhou Q, Chen M, Jiang O, Pan Y, Hu D, Lin Q, Wu G, Cui J, Chang J, Cheng Y, Huang C, Liu A, Yang N, Gong Y, Zhu C, Ma Z, Fang J, Chen G, Zhao J, Shi A, Lin Y, Li G, Liu Y, Wang D, Wu R, Xu X, Shi J, Liu Z, Cui N, Wang J, Wang Q, Zhang R, Yang J, Wu YL. Zhou Q, et al. Among authors: wang j. Lancet Oncol. 2022 Feb;23(2):209-219. doi: 10.1016/S1470-2045(21)00630-6. Epub 2022 Jan 14. Lancet Oncol. 2022. PMID: 35038429 Clinical Trial.
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial.
Zhou C, Wang Z, Sun Y, Cao L, Ma Z, Wu R, Yu Y, Yao W, Chang J, Chen J, Zhuang W, Cui J, Chen X, Lu Y, Shen H, Wang J, Li P, Qin M, Lu D, Yang J. Zhou C, et al. Among authors: wang j. Lancet Oncol. 2022 Feb;23(2):220-233. doi: 10.1016/S1470-2045(21)00650-1. Epub 2022 Jan 14. Lancet Oncol. 2022. PMID: 35038432 Clinical Trial.
Research Progress in Diffusion Spectrum Imaging.
Sun F, Huang Y, Wang J, Hong W, Zhao Z. Sun F, et al. Among authors: wang j. Brain Sci. 2023 Oct 23;13(10):1497. doi: 10.3390/brainsci13101497. Brain Sci. 2023. PMID: 37891866 Free PMC article. Review.
Regulation of signaling pathways in hair follicle stem cells.
Wang X, Liu Y, He J, Wang J, Chen X, Yang R. Wang X, et al. Among authors: wang j. Burns Trauma. 2022 Jul 4;10:tkac022. doi: 10.1093/burnst/tkac022. eCollection 2022. Burns Trauma. 2022. PMID: 35795256 Free PMC article. Review.
Eyelid cleaning: Methods, tools, and clinical applications.
Zhang L, Wang J, Gao Y. Zhang L, et al. Among authors: wang j. Indian J Ophthalmol. 2023 Dec 1;71(12):3607-3614. doi: 10.4103/IJO.IJO_1457_23. Epub 2023 Nov 20. Indian J Ophthalmol. 2023. PMID: 37991291 Free PMC article. Review.
205 results